MULTIMODALITY TREATMENT OF GLIOBLASTOMA PATIENTS USING DIFFERENT TEMOZOLOMIDE REGIMENS IN POSTOPERATIVE CHEMORADIOTHERAPY. (2017). Voprosy Onkologii, 63(6), 915-919. https://doi.org/10.37469/0507-3758-2017-63-6-915-919